Post by
SouthernTierTom on Aug 17, 2021 9:33am
Are American filtration companies "lost leaders"?
Last night I had several animals down with a variety of ailments. I took the time to resrearch some of the other "players" in the filtration game here in the US. Sure, I was aware of all of them, but wanted to better educate myself on their advancements, participants and most importantly current FDA status and real data that displayed efficacy and therefore chances of success.
My only conclusion to a rather detailed analysis of the current environment is that if Spectral doesn't continue to advance and complete their phase 4 confirmatory trial ( TIGRIS ), the filter plays here in the US will need a great deal of rapid advancement to bring excitement to their concepts, ideas and suggestions to market relevance. Their lack of US regulatory advancement and US patient experience places A LOT of need on Spectral to succeed - IMHO
Understand this Canada, as it relates to the mining industry...when your neighbor strikes gold at 2 oz. / tonne, the interest and value in your property skyrockets. I would argue that EDTXF has already provided some very nice "grades" as it relates to multiple FDA approvals and of course tidy relationships with the likes of Toray, InfoMed, Baxter, Fresenius and so on...HOWEVER, we'll need the golden FDA stamp on PMX to really make our "neighbor's stocks" move...Just my humble and modestly educated opinion ; - )
Perhaps why it has taken 5 years to produce 20 additional patients on the back of phase 3 data ( 5 years old ) that will provide a substantial amount of the phase 4 confirmatory data pack?
Comment by
FredrickHUGE on Aug 17, 2021 9:36am
This post has been removed in accordance with Community Policy
Comment by
FredrickHUGE on Aug 17, 2021 9:44am
This post has been removed in accordance with Community Policy